#EvidenceSynthesis
Publication bias concerns raised about a 2025 meta-analysis on postpartum haemorrhage prevention. A Lancet Global Health correspondence que…

#Evidencesynthesis #Metaanalysis #Oxytocin #Postpartumhaemorrhage #Publicationbias

#Evidencesynthesis #Metaanalysis #Oxytocin #Postpartumhaemorrhage #Publ…
Bias Concerns in Postpartum Haemorrhage Review
Publication bias concerns raised about a 2025 meta-analysis on postpartum haemorrhage prevention. A Lancet Global Health correspondence que… #Evidencesynthesis #Metaanalysis #Oxytocin #Postpartumhaemorrhage #Publicationbias
news.gmj.ge
November 1, 2026 at 5:26 PM
France upgrades Rinvoq’s adolescent benefit rating, but indirect evidence gaps remain.
https://www.mattheneus.com/editorial/has-rinvoq-upadacitinib-adolescent-atopic-dermatitis-benefit-upgrade-levelup-2026-09-23
#HTA #NMA #MAIC #EvidenceSynthesis
November 2, 2026 at 8:06 PM
Job entry, time worked and earnings need separate economic measures.
https://www.mattheneus.com/editorial/vocational-rehabilitation-employment-outcome-economic-denominator-2026-10-30
#HTA #HealthEconomics #EvidenceSynthesis
November 3, 2026 at 7:06 AM
France backs Talvey reimbursement but finds no added benefit despite updated evidence.
https://www.mattheneus.com/editorial/has-talvey-talquetamab-monotherapy-post-bcma-benefit-indirect-evidence-2026-09-09
#HTA #MAIC #EvidenceSynthesis
November 1, 2026 at 4:06 PM
Attack of the zombie reviews?🧟

To tackle the problem of zombie reviews — protocols & registrations abandoned without a complete review — senior editors of JBI Evidence Synthesis offer a comprehensive list of steps to address these issues.

https://ow.ly/veVi50ZZy0z

#JBIEBHC #EvidenceSynthesis
October 31, 2026 at 8:30 AM
A complete genomic assessment checklist is not proof of a validated framework. https://www.mattheneus.com/editorial/genomic-assessment-framework-coverage-versus-validation-2026-10-28 #HTA #EvidenceSynthesis #HealthEconomics
November 1, 2026 at 12:06 PM
Casgevy’s UK age extension highlights the limits of small, single-arm paediatric cohorts. https://www.mattheneus.com/editorial/mhra-casgevy-age-five-extension-paediatric-single-arm-evidence-2026-10-29 #HTA #MAIC #EvidenceSynthesis #RegulatoryAffairs
November 1, 2026 at 9:06 PM
Better balance is not proof of fewer falls: a 60-trial review exposes the active-comparator gap.
https://www.mattheneus.com/editorial/digital-balance-training-active-comparator-falls-endpoint-gap-2026-10-28
#HTA #NMA #MAIC #EvidenceSynthesis #HealthEconomics
November 2, 2026 at 7:07 AM
Polish patiromer advice highlights why subgroup differences can rule out evidence pooling.
https://www.mattheneus.com/editorial/aotmit-veltassa-patiromer-conditional-expansion-subgroup-synthesis-2026-10-26
#HTA #NMA #MAIC #EvidenceSynthesis
October 31, 2026 at 12:06 PM
Polish patiromer advice highlights why subgroup differences can rule out evidence pooling.
https://www.mattheneus.com/editorial/aotmit-veltassa-patiromer-conditional-expansion-subgroup-synthesis-2026-10-26
#HTA #NMA #MAIC #EvidenceSynthesis
October 31, 2026 at 12:06 PM
Placebo efficacy did not settle Dawnzera’s comparator case for Poland’s Transparency Council.
https://www.mattheneus.com/editorial/aotmit-dawnzera-donidalorsen-council-158-comparative-budget-uncertainty-2026-10-26
#HTA #MAIC #EvidenceSynthesis
October 30, 2026 at 5:06 PM
Placebo efficacy did not settle Dawnzera’s comparator case for Poland’s Transparency Council.
https://www.mattheneus.com/editorial/aotmit-dawnzera-donidalorsen-council-158-comparative-budget-uncertainty-2026-10-26
#HTA #MAIC #EvidenceSynthesis
October 30, 2026 at 5:06 PM
Denmark grants Posiforlid reimbursement using an acute-to-chronic evidence bridge.
https://www.mattheneus.com/editorial/danish-posiforlid-bibrocathol-blepharitis-conditional-reimbursement-2026-10-26
#HTA #EvidenceSynthesis
October 29, 2026 at 8:06 PM
Skyrizi’s new induction route beat placebo, but AFFIRM did not establish equivalence to intravenous induction. https://www.mattheneus.com/editorial/fda-skyrizi-subcutaneous-crohn-induction-affirm-placebo-comparator-2026-10-23 #HTA #MAIC #EvidenceSynthesis
October 30, 2026 at 12:06 PM
Denmark grants Posiforlid reimbursement using an acute-to-chronic evidence bridge.
https://www.mattheneus.com/editorial/danish-posiforlid-bibrocathol-blepharitis-conditional-reimbursement-2026-10-26
#HTA #EvidenceSynthesis
October 29, 2026 at 8:06 PM
Today, the importance of #EvidenceSynthesis methods for collating & rigorously integrating information has never been greater state Martin et al. As authors often fail to apply the methods robustly, Martin et al. describe 16 criteria to guide the preparation of such syntheses doi.org/10.1111/1365...
November 2, 2026 at 11:56 AM
Skyrizi’s new induction route beat placebo, but AFFIRM did not establish equivalence to intravenous induction. https://www.mattheneus.com/editorial/fda-skyrizi-subcutaneous-crohn-induction-affirm-placebo-comparator-2026-10-23 #HTA #MAIC #EvidenceSynthesis
October 30, 2026 at 12:06 PM
#CochraneDaily

In October 2026, the @cochrane.org Library published 12 new reviews, 2 updated reviews where the conclusions had changed and no updated reviews where the conclusions had not changed. See them at www.cochranelibrary.com/cdsr/table-o...

#CochraneLibrary #EvidenceSynthesis
Cochrane Database of Systematic Reviews: all issues | Cochrane Library
Table of Contents Issues provide the back issues for all the CDSR content.
www.cochranelibrary.com
November 3, 2026 at 2:31 PM
The scariest thing on Halloween? Letting good climate evidence gather cobwebs. 🕸️
Clear them out with this month’s WWCS newsletter 🎃

🌍 Syntheses, Support, Spotlights: the WWCS #ClimateSolutions newsletter brings you news you can use 👻 #WhatWorks @unep.org @cochrane.org @lancetcountdown.bsky.social
#climatesolutions #emissionsgap #wwcscrowd #cop31 #climatesolutions #climatepolicy #wwcs #evidencesynthesis #lancetcountdown #wwcssummit2027 | What Works Climate Solutions
🌍 Syntheses, Support, Spotlights — the WWCS #ClimateSolutions newsletter brings you Syntheses we’re profiling, Support we’re building, and Spotlights on people, partners, and progress. This month: 🔬 ...
www.linkedin.com
October 31, 2026 at 12:40 PM
Hospital AI evidence skews toward diagnostics and screening in a review of 30 assessment reports. https://www.mattheneus.com/editorial/hospital-ai-assessment-diagnostic-heavy-corpus-transferability-2026-10-22 #HTA #EvidenceSynthesis
October 29, 2026 at 6:06 PM
Hospital AI evidence skews toward diagnostics and screening in a review of 30 assessment reports. https://www.mattheneus.com/editorial/hospital-ai-assessment-diagnostic-heavy-corpus-transferability-2026-10-22 #HTA #EvidenceSynthesis
October 29, 2026 at 6:06 PM
Positive Rinvoq advice does not establish comparative equivalence.
https://www.mattheneus.com/editorial/zin-rinvoq-giant-cell-arteritis-revised-positive-advice-comparison-limitations-2026-10-22
#HTA #MAIC #EvidenceSynthesis
October 28, 2026 at 8:06 PM
Positive Rinvoq advice does not establish comparative equivalence.
https://www.mattheneus.com/editorial/zin-rinvoq-giant-cell-arteritis-revised-positive-advice-comparison-limitations-2026-10-22
#HTA #MAIC #EvidenceSynthesis
October 28, 2026 at 8:06 PM
A weight-loss bundle’s benefit does not tell you what each component adds.
https://www.mattheneus.com/editorial/digital-weight-loss-bundle-component-attribution-service-costs-2026-10-23
#HTA #NMA #EvidenceSynthesis #HealthEconomics
October 28, 2026 at 1:06 PM
A weight-loss bundle’s benefit does not tell you what each component adds.
https://www.mattheneus.com/editorial/digital-weight-loss-bundle-component-attribution-service-costs-2026-10-23
#HTA #NMA #EvidenceSynthesis #HealthEconomics
October 28, 2026 at 1:06 PM